A study published in JAMA Network Open August 11 suggests that, despite the growing use of imaging modalities like computed tomography and MRI, echocardiography remains the most popular method for imaging patients with heart failure.
Volunteers in Bend, Ore., are advocating for more widespread “Stop the Bleed” training after back-to-back mass shootings earlier this month left 31 dead, local paper the Bulletin reported August 11.
Cerner Corporation has partnered with the Duke Clinical Research Institute to pilot the Cerner Learning Health Network, an evolving database that aims to automate data collection for rapid access to contemporary medical information.
Researchers at Beth Israel Deaconess Medical Center in Boston have developed an imaging technique that allows physicians to diagnose CAD without the risk of a contrast agent.
Patients with critical limb ischemia might be better off if they opt for endovascular-first treatment over an open surgical bypass, a Circulation: Cardiovascular Quality and Outcomes study suggests.
Corindus Vascular Robotics on August 8 announced it had entered a definitive merger agreement with Siemens Healthineers, which will reportedly acquire Corindus for a price of $1.1 billion.
The director of Duke University’s heart transplant program is promoting warm perfusion—a technique that preserves organs more effectively than a traditional cooling box—as a means of expanding the CV donor pool in the U.S.
Newly diagnosed HF patients with concomitant mitral regurgitation can expect more admissions, longer hospital stays and pricier medical bills than HF patients without MR, according to an analysis published in the American Journal of Cardiology.
The FDA issued an advisory August 7 updating healthcare providers and the public on its stance regarding the long-term safety of paclitaxel-coated and -eluting devices, sharing that its expert panel had indeed identified a late mortality signal associated with the devices.
